SCHEMBL6625943

SCHEMBL6625943

CCNC(=O)c1cccc(CNC(=O)OC(C)(C)C)c1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MMP13 P45452 1/20 0.51
NR1H4 Q96RI1 1/20 0.51
ROCK2 O75116 4/20 0.50
ROCK1 Q13464 3/20 0.50
SMN1; SMN2 Q16637 1/20 0.49
LMNA P02545 1/20 0.49
HPGD P15428 1/20 0.49
GLS O94925 2/20 0.47
KDM4A O75164 1/20 0.47
MRGPRX4 Q96LA9 1/20 0.47
NAMPT P43490 2/20 0.46
PARP1 P09874 1/20 0.46
HDAC1 Q13547 1/20 0.46
PPARG P37231 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20474743 0.88 HDAC6 (0.56) MMP13NR1H4LMNAHPGDGLS
SCHEMBL13999403 0.87 ROCK2 (0.50) MMP13NR1H4ROCK2ROCK1LMNA
SCHEMBL13135999 0.85 GLS (0.50) MMP13NR1H4GLSKDM4ANAMPT
SCHEMBL184425 0.85 NR1H4 (0.61) MMP13NR1H4GLSKDM4ANAMPT
SCHEMBL879574 0.84 LOXL2 (0.56) MMP13NR1H4ROCK2ROCK1GLS
SCHEMBL31044413 0.84 GLS (0.49) MMP13NR1H4GLSKDM4ANAMPT
SCHEMBL6622954 0.83 NAMPT (0.59) NR1H4LMNANAMPTHDAC1HDAC8
SCHEMBL24140014 0.83 ALDH1A1 (0.49) MMP13NR1H4GLSKDM4ANAMPT
SCHEMBL13862398 0.83 LCK (0.53) MMP13NR1H4ROCK2SMN1; SMN2HPGD
SCHEMBL5564933 0.83 SMYD3 (0.55) NR1H4ROCK2ROCK1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1487455-A1 MORPHOLINE DERIVATIVES SUBSTITUTED AT THE 2-POSITION BY AN ARYLALKYLUREA GROUP FOR USE AS CCR-3 ANTAGONISTS IN THE TREATMENT OF INFLAMMATORY CONDITIONS GLAXO GROUP LIMITED (GB) 2004-12-22 EP disclosed
WO-2003082292-A1 MORPHOLINE DERIVATIVES SUBSTITUTED AT THE 2-POSITION BY AN ARYLALKYLUREA GROUP FOR USE AS CCR-3 ANTAGONISTS IN THE TREATMENT OF INFLAMMATORY CONDITIONS GLAXO GROUP LIMITED (GB) 2003-10-09 WO disclosed